Among KRAS mutations, KRAS-G12C mutation is a single point mutation with a glycine-to-cysteine substitution at codon 12, which can be observed in colorectal and pancreatic cancers, and is particularly prevalent in non-small cell lung cancer (NSCLC) (Shin et al., 2019). This evidence concerns the gene KRAS and non-small cell lung carcinoma.